Prostate Cancer Genomics, Biology, and Risk Assessment Through Genome-wide Association Studies

Overview

Journal Cancer Sci

Specialty Oncology

Date 2011 Dec 21

PMID 22181854

Citations 19

Authors

Hidewaki Nakagawa

Shusuke Akamatsu

Ryo Takata

Atsushi Takahashi

Michiaki Kubo

Yusuke Nakamura

Affiliations

Soon will be listed here.

Abstract

Prostate cancer (PC) is the most common malignancy observed in men. It is evident that genetic factors play some important roles in PC etiology. Recently, genome-wide association studies in diverse ethnic groups have identified more than 40 germline variants of various genes or chromosomal loci that are significantly associated with PC susceptibility, including multiple 8q24 loci, prostate-specific genes, metabolic and hormone-related genes, and many regions where no coding gene is annotated. However, there are only a few variants or genes for which biological significance or functions have been elucidated so far. The greatest challenge related to genome-wide association studies loci in prostate genomics is to understand the functional consequences of these PC-associated loci and their involvement in PC biology and carcinogenesis. There have been attempts to determine PC risk estimations by combining multiple PC-associated variants for clinical tests, and these can identify a very minor population with high risk of PC. However, they cannot distinguish risk of aggressive PC from that of non-aggressive PC. Further identification of PC-susceptibility loci in larger genome-wide association studies cohorts and biological insights gained from such functional analyses have the potential to translate into clinical benefits, including the development of reliable biomarkers, risk estimation, and effective strategies for screening and prevention of PC.

Citing Articles

Genetically Predicted Circulating Concentrations of Alanine and Alanine Aminotransferase Were Associated with Prostate Cancer Risk.

Yang S, Song J, Yang H, Liu W, Jiang Y, Sun X Clin Epidemiol. 2022; 14:1255-1264.

PMID: 36330075 PMC: 9624164. DOI: 10.2147/CLEP.S382116.

Polymorphic variants of the CASP3, CASP9, BCL-2 and NKX3-1 genes as candidate markers for prostate cancer susceptibility and poor prognosis.

de Souza M, Souza M, DE Nobrega M, Ciliao H, Dos Reis M, Fuganti P Mol Biol Rep. 2022; 49(9):9079-9087.

PMID: 35708863 DOI: 10.1007/s11033-022-07654-0.

MiR-205-5p Functions as a Tumor Suppressor in Gastric Cancer Cells through Downregulating FAM84B.

Chen X, Zhang L, Geng J, Chen Z, Cui X J Oncol. 2022; 2022:8267891.

PMID: 35669244 PMC: 9166972. DOI: 10.1155/2022/8267891.

The Sca-1 and Sca-1 mouse prostatic luminal cell lineages are independently sustained.

Kwon O, Choi J, Zhang L, Jia D, Li Z, Zhang Y Stem Cells. 2020; 38(11):1479-1491.

PMID: 32627901 PMC: 7606766. DOI: 10.1002/stem.3253.

The Oncogenic Potential of the Centromeric Border Protein FAM84B of the 8q24.21 Gene Desert.

Gu Y, Lin X, Kapoor A, Chow M, Jiang Y, Zhao K Genes (Basel). 2020; 11(3).

PMID: 32183428 PMC: 7140883. DOI: 10.3390/genes11030312.

References

Tavtigian S, Simard J, Teng D, Abtin V, Baumgard M, Beck A . A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet. 2001; 27(2):172-80. DOI: 10.1038/84808. View

Nam R, Zhang W, Trachtenberg J, Seth A, Klotz L, Stanimirovic A . Utility of incorporating genetic variants for the early detection of prostate cancer. Clin Cancer Res. 2009; 15(5):1787-93. DOI: 10.1158/1078-0432.CCR-08-1593. View

Tuupanen S, Turunen M, Lehtonen R, Hallikas O, Vanharanta S, Kivioja T . The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat Genet. 2009; 41(8):885-90. DOI: 10.1038/ng.406. View

Eeles R, Kote-Jarai Z, Giles G, Olama A, Guy M, Jugurnauth S . Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet. 2008; 40(3):316-21. DOI: 10.1038/ng.90. View

Eeles R, Kote-Jarai Z, Olama A, Giles G, Guy M, Severi G . Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet. 2009; 41(10):1116-21. PMC: 2846760. DOI: 10.1038/ng.450. View

He W, Sciavolino P, Wing J, Augustus M, Hudson P, Meissner P . A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. Genomics. 1997; 43(1):69-77. DOI: 10.1006/geno.1997.4715. View

Fackenthal J, Olopade O . Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer. 2007; 7(12):937-48. DOI: 10.1038/nrc2054. View

Zanke B, Greenwood C, Rangrej J, Kustra R, Tenesa A, Farrington S . Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet. 2007; 39(8):989-94. DOI: 10.1038/ng2089. View

Olama A, Kote-Jarai Z, Giles G, Guy M, Morrison J, Severi G . Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet. 2009; 41(10):1058-60. DOI: 10.1038/ng.452. View

10.

Gudmundsson J, Sulem P, Gudbjartsson D, Blondal T, Gylfason A, Agnarsson B . Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat Genet. 2009; 41(10):1122-6. PMC: 3562712. DOI: 10.1038/ng.448. View

11.

Xu J, Sun J, Kader A, Lindstrom S, Wiklund F, Hsu F . Estimation of absolute risk for prostate cancer using genetic markers and family history. Prostate. 2009; 69(14):1565-72. PMC: 2793526. DOI: 10.1002/pros.21002. View

12.

Soranzo N, Rivadeneira F, Chinappen-Horsley U, Malkina I, Richards J, Hammond N . Meta-analysis of genome-wide scans for human adult stature identifies novel Loci and associations with measures of skeletal frame size. PLoS Genet. 2009; 5(4):e1000445. PMC: 2661236. DOI: 10.1371/journal.pgen.1000445. View

13.

Haiman C, Patterson N, Freedman M, Myers S, Pike M, Waliszewska A . Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet. 2007; 39(5):638-44. PMC: 2638766. DOI: 10.1038/ng2015. View

14.

Wang X, Kruithof-de Julio M, Economides K, Walker D, Yu H, Halili M . A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature. 2009; 461(7263):495-500. PMC: 2800362. DOI: 10.1038/nature08361. View

15.

Konety B, Bird V, Deorah S, Dahmoush L . Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era. J Urol. 2005; 174(5):1785-8. DOI: 10.1097/01.ju.0000177470.84735.55. View

16.

Lindner T, Njolstad P, Horikawa Y, Bostad L, Bell G, Sovik O . A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1beta. Hum Mol Genet. 1999; 8(11):2001-8. DOI: 10.1093/hmg/8.11.2001. View

17.

Chu L, Meyer T, Li Q, Menashe I, Yu K, Rosenberg P . Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin. Cancer Epidemiol Biomarkers Prev. 2010; 19(7):1848-54. PMC: 2901401. DOI: 10.1158/1055-9965.EPI-10-0101. View

18.

Sun J, Zheng S, Wiklund F, Isaacs S, Purcell L, Gao Z . Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. Nat Genet. 2008; 40(10):1153-5. PMC: 3188432. DOI: 10.1038/ng.214. View

19.

Robbins C, Torres J, Hooker S, Bonilla C, Hernandez W, Candreva A . Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus. Genome Res. 2007; 17(12):1717-22. PMC: 2099580. DOI: 10.1101/gr.6782707. View

20.

Tomlinson I, Webb E, Carvajal-Carmona L, Broderick P, Kemp Z, Spain S . A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet. 2007; 39(8):984-8. DOI: 10.1038/ng2085. View